V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003681 | 210012501 | 1.6 | 88.5 | Palliative (P) | null | 2022-03-24 | VINORELBINE | 02 | N | VINORELBINE | 101205386 |
| 210003686 | 210012502 | 1.58 | 102.5 | Adjuvant (A) | 2020-11-06 | 2020-11-13 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101457830 |
| 210003690 | 210012504 | 1.65 | 72.4 | Neo-adjuvant (N) | 2021-05-27 | 2021-05-28 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100856400 |
| 210003697 | 210012507 | 1.57 | 85.4 | Adjuvant (A) | 2017-08-09 | 2017-11-30 | Doce + Pertuzumab + Trastuz IV Load | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100712049 |
| 210003698 | 210012508 | null | 56 | Neo-adjuvant (N) | 2021-03-31 | 2021-04-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100105527 |
| 210003703 | 210012509 | 0 | 63.5 | Palliative (P) | 2020-11-09 | 2020-11-24 | null | 02 | N | EPIRUBICIN | 101702403 |
| 210003705 | 210012510 | 1.6 | 54.05 | Adjuvant (A) | null | 2019-11-28 | null | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100776863 |
| 210003716 | 210012513 | 1.71 | 71.4 | null | 2021-01-15 | 2021-01-31 | null | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100856886 |
| 210003719 | 210012515 | null | null | Palliative (P) | 2019-05-21 | 2019-07-17 | Fulvestrant + Palbociclib | 02 | N | CYCLO + DOCETAXEL + TRASTUZUMAB | 101426308 |
| 210003720 | 210012516 | 1.6 | null | Adjuvant (A) | 2021-07-07 | 2021-07-28 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | 02 | N | LETROZOLE + PALBOCICLIB | 101512375 |
| 210003721 | 210012517 | 1.57 | 76.2 | Adjuvant (A) | 2020-04-17 | 2020-05-11 | Pertuzumab (Loading) | 02 | N | PERTUZUMAB | 100577965 |
| 210003723 | 210012519 | 1.6 | 96.3 | null | 2019-09-20 | 2019-12-02 | null | 02 | null | TRASTUZUMAB DERUXTECAN | 100832036 |
| 210003725 | 210012520 | 1.78 | 0 | Palliative (P) | 2017-08-28 | 2017-12-09 | Fulvestrant + Palbociclib | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100388097 |
| 210003728 | 210012522 | 1.61 | 0 | null | null | 2018-08-28 | null | 02 | null | NAB-PACLITAXEL | 100605706 |
| 210003729 | 210012523 | 1.63 | 71.5 | Palliative (P) | 2020-03-16 | 2020-04-15 | null | 02 | N | FEC + DOCETAXEL | 100347717 |
| 210003741 | 210012527 | 1.67 | 65.65 | null | 2018-03-22 | 2018-04-10 | null | 02 | null | EPIRUBICIN | 100738148 |
| 210003742 | 210012528 | 1.59 | 89.4 | Palliative (P) | 2021-01-08 | 2021-01-25 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100243128 |
| 210003743 | 210012529 | 1.58 | 53 | null | 2019-07-31 | 2019-08-14 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100196066 |
| 210003749 | 210012531 | 1.66 | 93 | Neo-adjuvant (N) | 2020-09-13 | 2020-09-29 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101397605 |
| 210003768 | 210012540 | 1.72 | 92.8 | Neo-adjuvant (N) | 2021-03-08 | 2021-03-18 | ROSCO Trial | 02 | N | TRASTUZUMAB EMTANSINE | 101547987 |
| 210003773 | 210012542 | null | null | null | 2022-04-16 | 2022-04-29 | FEC | 02 | null | CARBOPLATIN + PACLITAXEL | 101108908 |
| 210003776 | 210012543 | 1.57 | 59.2 | null | null | 2021-09-10 | Eribulin | 02 | null | ERIBULIN | 100501252 |
| 210003778 | 210012544 | 1.74 | 79.6 | null | null | 2019-08-15 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100265116 |
| 210003782 | 210012547 | 1.68 | 75.9 | null | 2017-08-19 | 2017-08-27 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100450489 |
| 210003783 | 210012548 | null | null | null | 2021-04-20 | 2021-07-07 | Pertuzumab (Loading) | null | null | PERTUZUMAB | 100235204 |
| 210003790 | 210012549 | 1.64 | 57.9 | null | 2018-11-24 | 2018-12-23 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101234165 |
| 210003794 | 210012551 | 1.52 | 93 | null | 2020-02-01 | 2020-03-22 | Neratinib | 02 | null | NERATINIB | 101774771 |
| 210003802 | 210012554 | null | 102.5 | Adjuvant (A) | 2018-11-06 | 2019-03-31 | PERTUZUMAB + TRASTUZUMAB | null | N | PERTUZUMAB + TRASTUZUMAB | 101468225 |
| 210003806 | 210012557 | null | null | null | 2022-01-17 | 2022-02-11 | Capecitabine | 02 | null | CAPECITABINE | 101532763 |
| 210003808 | 210012559 | null | 107 | null | 2019-11-22 | 2020-02-03 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100749803 |
| 210003811 | 210012561 | 1.59 | 83.2 | Neo-adjuvant (N) | 2017-02-02 | 2017-02-16 | null | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB | 100844377 |
| 210003818 | 210012564 | null | null | null | 2020-08-01 | 2020-08-24 | EC | 02 | null | EC | 101420244 |
| 210003821 | 210012566 | null | 67.4 | null | 2021-06-18 | 2021-06-26 | TCH (21 day Trastuzumab) Maint | null | null | LETROZOLE + PALBOCICLIB | 101309940 |
| 210003824 | 210012568 | null | null | null | null | 2018-11-28 | null | 02 | null | EPIRUBICIN | 100036411 |
| 210003829 | 210012570 | 1.56 | 77.4 | Palliative (P) | null | 2019-11-17 | null | null | N | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100506263 |
| 210003830 | 210012571 | null | null | Adjuvant (A) | 2018-10-19 | 2018-11-08 | null | null | N | PALBOCICLIB | 101383942 |
| 210003832 | 210012572 | 0 | 70.4 | Neo-adjuvant (N) | 2019-07-18 | 2019-09-28 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100586130 |
| 210003838 | 210012575 | 1.66 | null | null | 2021-10-25 | 2021-10-29 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101607323 |
| 210003845 | 210012577 | 1.51 | 66.5 | null | 2021-09-26 | 2021-12-06 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 100474186 |
| 210003850 | 210012581 | 1.62 | 80 | Palliative (P) | 2019-10-28 | 2019-11-06 | null | 01 | N | TAC | 100865385 |
| 210003852 | 210012583 | 1.58 | 89.3 | Palliative (P) | 2019-04-21 | 2019-05-03 | Capecitabine | 02 | N | CAPECITABINE | 100647356 |
| 210003857 | 210012585 | 1.66 | 96 | null | 2017-08-12 | 2019-05-28 | Palbociclib | 02 | null | TRASTUZUMAB EMTANSINE | 100064061 |
| 210003858 | 210012586 | 1.48 | 98.2 | Palliative (P) | null | 2016-10-11 | null | 02 | N | TRIAL UNSPECIFIED | 101594501 |
| 210003859 | 210012587 | 1.62 | 89 | Neo-adjuvant (N) | 2019-03-22 | 2019-04-12 | EC | null | N | EC | 100934002 |
| 210003864 | 210012589 | 1.52 | null | Palliative (P) | null | 2019-11-10 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100309071 |
| 210003870 | 210012590 | 1.64 | null | Palliative (P) | 2019-11-01 | 2019-11-21 | null | N | N | PACLITAXEL + TRASTUZUMAB | 101050368 |
| 210003876 | 210012594 | 1.68 | 78.7 | Palliative (P) | 2018-04-26 | 2018-05-12 | Everolimus 10mg | N | N | CARBOPLATIN + DOCETAXEL | 100468627 |
| 210003879 | 210012596 | 1.62 | 55 | Curative (C) | 2021-12-30 | 2021-12-31 | Letrozole + Palbociclib | N | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 100017528 |
| 210000062 | 210012599 | 1.7 | 96 | Adjuvant (A) | 2018-07-27 | 2018-12-03 | Carboplatin + Docetaxel | null | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100225173 |
| 210000169 | 210012600 | 1.62 | 88.7 | null | 2021-05-24 | 2021-05-27 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | null | VINORELBINE | 101740701 |